The Food and Drug Administration today revised the Janssen COVID-19 vaccine fact sheet for healthcare providers to include a warning of an observed increased risk of Guillain-Barré Syndrome following vaccination with the Johnson & Johnson vaccine, according to an FDA spokesperson.
FDA warns of an increased risk of Guillain-Barré Syndrome following vaccination with the J & J vaccine
